We're Here for You!
The IMF is dedicated to improving the quality of life of myeloma patients while working toward prevention and a cure.
I am a...
I am a...
This September, the International Myeloma Foundation (IMF) will take part in Blood Cancer Awareness Month (BCAM). The global initiative focuses on all blood cancers, with myeloma ranking as the second most common of these diseases. Throughout the month the IMF will ask one simple question: "Do You Know Myeloma? Click here to learn about the IMF's BCAM initiatives.
After completing two years of treatment, Leo Dierckman has now been off all therapy for over a year and is negative, he tells IMF Chairman Dr. Brian G.M. Durie.
The IMF is very pleased to note the full FDA approval of the Pfizer-BioNTech COVID-19 vaccine. This reflects what has been both remarkable efficacy plus and an excellent safety profile. This full approval versus versus the prior Emergency Use Authorization (EUA) will encourage those with vaccine hesitancy to proceed with vaccination. In addition, doctors now have flexibility to prescribe booster shots as appropriate. In the workplace, many more vaccine mandates are now anticipated which can definitely improve safety overall.
To spread the word about the risk and impact of in the African-American community, the IMF is presenting a free, virtual myeloma workshop on Saturday, September 25, at 10 a.m. ET. This workshop is part of the IMF’s initiative in Baltimore and surrounding areas to change the course of by removing barriers to early diagnosis and treatment for African Americans (for whom myeloma is two times more prevalent than it is in all other races).
Need to stay informed about the news that impacts myeloma patients, but don’t have time to read everything out there? Then be sure to follow Dr. Brian Durie’s Week in Review blog. The leading myeloma expert and IMF Chairman of the Board drills down on a wide range of topics – from the latest myeloma research results to the environmental issues that offer insight into prevention. He sifts through the data to deliver the bottom line.
Last year marks the International Myeloma Foundation's (IMF) 30th anniversary, celebrating 30 years of scientific achievement with myeloma patient care at the heart of it all. What started in a garage with a borrowed typewriter is now the largest organization focused specifically on . The IMF continues to push the needle forward toward a cure for myeloma with cure-focused trials and over 40 active research projects around the world. As IMF President and Founder Susie Durie says, "We are this close to the cure. I can see it on the horizon."
The support of loved ones allows us to continue to fund efforts to search for a cure. Check out how Fundraisers are helping in the fight against myeloma.
